The Role of Anti-Müllerian Hormone (AMH) Trends in Predicting Ovarian Reserve in Women Under 30
DOI:
https://doi.org/10.63682/jns.v13i1.8987Keywords:
Anti-Müllerian hormone (AMH), ovarian reserve, fertility, antral follicle count, young women, reproductive age, hormonal profileAbstract
Background: To assess the pattern of serum AMH levels and their correlation with ovarian reserve markers in females below thirty years of age.
Methods: A prospective observational study was conducted from June 2023 to June 2024 involving 61 women aged 18–29 years. Data on demographics, menstrual history, and family history of early menopause were collected. Hormonal analysis included AMH, FSH, LH, and estradiol, while ovarian reserve was assessed via antral follicle count (AFC) using transvaginal ultrasound. Statistical analysis was performed to evaluate associations between AMH and other variables.
Results: AMH levels showed a significant decline with increasing age, even within the studied age range. ‘A strong positive correlation was found between AMH and AFC, while inverse relationships were noted with FSH and estradiol’. Irregular menstrual cycles were also significantly associated with lower AMH levels.
Conclusion: AMH is a valuable, early marker of ovarian reserve in women under 30. Its decline with age—even in young women—emphasizes the need for early fertility awareness and personalized reproductive counseling.
Downloads
Metrics
References
Moolhuijsen, L.M., J.A.J.T.J.o.C.E. Visser, and Metabolism, Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. 2020. 105(11): p. 3361-3373.
Xu, H., et al., An ovarian reserve assessment model based on anti-müllerian hormone levels, follicle-stimulating hormone levels, and age: Retrospective cohort study. 2020. 22(9): p. e19096.
Tehrani, F.R., et al., Investigating the clinical utility of the anti-mullerian hormone testing for the prediction of age at menopause and assessment of functional ovarian reserve: a practical approach and recent updates. 2022. 13(2): p. 458.
Han, Y., et al., An online tool for predicting ovarian reserve based on AMH level and age: A retrospective cohort study. 2022. 13: p. 946123.
Cedars, M.I.J.T.J.o.C.E. and Metabolism, Evaluation of female fertility—AMH and ovarian reserve testing. 2022. 107(6): p. 1510-1519.
Ramezani Tehrani, F., et al., Does the anti-Mullerian hormone decline rate improve the prediction of age at menopause? 2021. 12: p. 727229.
Das, S., et al., Correlation of Follicle-stimulating Hormone, Anti-Mullerian Hormone, and Antral Follicle Count with Age in Ovarian Reserve Testing. 2024. 14(3): p. 162-168.
Bedenk, J., et al., The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility. 2020. 37(1): p. 89-100.
Anderson, R.A., et al., Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. 2022. 28(3): p. 417-434.
Burak, Ü., B.Ç.J.O. ÜN, and G. I, THE RELATIONSHIP BETWEEN ANTI-MÜLLERIAN HORMONE (AMH) AND FEMALE FERTILITY. 2024: p. 41.
Huang, Y., et al., Using anti-Müllerian hormone to predict premature ovarian insufficiency: a retrospective cross-sectional study. 2024. 15: p. 1454802.
Iwase, A., et al., Anti-Müllerian hormone beyond an ovarian reserve marker: the relationship with the physiology and pathology in the life-long follicle development. 2023. 14: p. 1273966.
Oldfield, A.L., M. Kazemi, and M.E.J.J.o.C.M. Lujan, Impact of obesity on anti-mullerian hormone (AMH) levels in women of reproductive age. 2021. 10(14): p. 3192.
Butt, M.S., et al., Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age. 2022. 22(1): p. 199.
Gunasheela, D., et al., Age-specific distribution of serum anti-mullerian hormone and antral follicle count in Indian infertile women. 2021. 14(4): p. 372-379.
Lin, C., et al., The value of anti-Müllerian hormone in the prediction of spontaneous pregnancy: a systematic review and meta-analysis. 2021. 12: p. 695157.
Rios, J.S., et al., Associations between anti-mullerian hormone and cardiometabolic health in reproductive age women are explained by body mass index. 2020. 105(3): p. e555-e563.
Koller, T., et al., Ovarian reserve assessed by the anti-Mullerian hormone and reproductive health parameters in women with Crohn’s disease, a case-control study. 2021. 70(Suppl 1): p. S69.
Wang, X., et al., Evaluation of ovarian reserve tests and age in the prediction of poor ovarian response to controlled ovarian stimulation—A real-world data analysis of 89,002 patients. 2021. 12: p. 702061.
Hariton, E., et al., Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals. 2021. 225(5): p. 515. e1-515. e10.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
